Are pregnancy and ART reasonable after breast cancer?;La grossesse et l'AMP sont-elles raisonnables après un cancer du sein?

Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie

Volumn 10, Issue 4, 2008, Pages 272-276

  Rouzier, Roman ^a,b   Uzan, Catherine ^c   Lesieur, Benedicte ^a,b   Vercambre, Marie ^a,b   Chabbert Buffet, Nathalie ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Breast cancer; Fertility; Preservation

Indexed keywords

EID: 55849147043     PISSN: 1774640X     EISSN: None     Source Type: Journal    
DOI: 10.1684/mte.2008.0167     Document Type: Review

References (34)

1. McCarthy NJ. Care of the breast cancer survivor : increased survival rates present a new set of challenges. Postgrad Med 2004 ; 116 : 39-40.
2. Gadducci A, Cosio S, Genazzani AC. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endocrinol 2007 ; 23 : 625-31.
3. Shahin MS, Puscheck E. Reproductive sequelae of cancer treatment. Obstet Gynecol Clin North Am 1998 ; 25 : 423-33.
4. Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 2002 ; 9 : 466-72.
5. Searns V, Schneider B, Henry NL, Hayes DF, Flockhart DA. Breast cancer treatment and ovarian failure : risk factors and emerging genetic determinants. Nat Rev Cancer 2006 ; 6 : 886-93.
6. Hortobagyi GN, Buzdar AU, Marcus CE, Smith TL. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr 1986 ; 1 : 105-9.
7. Fornier MN, Modi S, Panageas KS, Norton L, Hudis C. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005 ; 104 : 1575-9.
8. Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 2007 ; 30 : 126-32.
9. van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility : a longitudinal study. Fertil Steril 2005 ; 83 : 979-87.
10. Anders C, Marcom PK, Peterson B, et al. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest 2008 ; 26 : 286-95.
11. Pritchard KI. Adjuvant therapy for premenopausal women with breast cancer : is it time for another paradigm shift? J Clin Oncol 2002 ; 20 : 4611-4.
12. De Haes H, Olschewski M, Kaufmann M, Schumacher M, Jonat W, Sauerbrei W. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer : the zoladex early Breast Cancer Research Association Trialists Group. J Clin Oncol 2003 ; 21 : 4510-6.
13. Colleoni M, Gelber S, Goldhirsch A, et al. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer : International Breast Cancer Study Group Trial 13-93. J Clin Oncol 2006 ; 24 : 1332-41.
14. Gnant M, Greil R, Kubista E, et al. The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer : 10-year result of ABCSG-05 (CMF versus goserelin + tamoxifen). Breast Cancer Res Treat 2006 ; 100 : S10.
15. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006 ; 24 : 5769-79.
16. Cuzick J. The impact of LHRH agonists on breast cancer recurrence and mortality : an overview of the randomized trials. Breast Cancer Res Treat 2006 ; 100 : S10.
17. Vanhuyse M, Fournier C, Bonneterre J. Chemotherapy induced amenorrhea : influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients. Ann Oncol 2005 ; 16 : 1283-8.
18. Braverman AS, Sawhney H, Tendler A, Patel N, Rao CS. Premenopausal serum estradiol levels may persist after chemotherapy-induced amenorrhea in breast cancer. Proc Am Soc Clin Oncol 2002 ; 21 : 42a ; (abstract 164).
19. Ellmen J, Hakulinen P, Partanen A, Hayes DF. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients. Breast Cancer Res Treat 2003 ; 82 : 103-11.
20. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton 3rd LJ. Survival patterns after oophorectomy in premenopausal women : a population-based cohort study. Lancet Oncol 2006 ; 7 : 821-8.
21. Cooper DR, Butterfield J. Pregnancy subsequent to mastectomy for cancer of the breast. Ann Surg 1970 ; 171 : 429-33.
22. Ariel IM, Kempner R. The prognosis of patients who become pregnant after mastectomy for breast cancer. Int Surg 1989 ; 74 : 185-7.
23. Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy : «healthy mother effect». Am J Obstet Gynecol 1994 ; 170 : 818-23.
24. von Schoultz E, Johansson H, Wilking N, Rutqvist LE. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 1995 ; 13 : 430-4.
25. Kroman N, Jensen MB, Melbye M, Wohlfahrt J, Mouridsen HT. Should women be advised against pregnancy after breast cancer treatment? Lancet 1997 ; 350 : 319-22.
26. Gelber S, Coates AS, Goldhirsh A, et al., International Breast Cancer Study Group. Effect of pregnancy on overall survival after the diagnosis of early stage breast cancer. J Clin Oncol 2001 ; 19 : 1671-5.
27. Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 2004 ; 100 : 465-9.
28. Averette HE, Mirhashemi R, Moffat FL. Pregnancy after breast carcinoma: the ultimate medical challenge. Cancer. 1999; 85: 2301-4.
29. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001 ; 19 : 980-91.
30. Gerber B, Dieterich M, Müller H, Reimer T. Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Res Treat 2008 ; 108 : 1-7.
31. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients : IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003 ; 18 : 90-5.
32. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006 ; 91 : 3885-90.
33. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients : a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005 ; 23 : 4347-53.
34. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet 1999 ; 354 : 1586-90.